Kaposi's sarcoma in rheumatoid arthritis

Area of Science:

• Rheumatology
• Dermatology
• Oncology

Background:

• Systemic rheumatoid disease encompasses conditions like rheumatoid arthritis, Felty's syndrome, rheumatoid vasculitis, and myositis.
• Immunosuppressive therapy, particularly corticosteroids like prednisone, is often used to manage severe autoimmune conditions.
• Cutaneous Kaposi's sarcoma is an opportunistic malignancy typically associated with human immunodeficiency virus (HIV) infection.

Observation:

• A 58-year-old male patient with a history of systemic rheumatoid disease presented with a new diagnosis of cutaneous Kaposi's sarcoma.
• The patient had been undergoing treatment with prednisone for eight months prior to the Kaposi's sarcoma diagnosis.
• Crucially, the patient was not diagnosed with acquired immune deficiency syndrome (AIDS).

Findings:

• The development of Kaposi's sarcoma occurred in the context of prolonged corticosteroid use for rheumatoid disease.
• The absence of HIV infection in this patient distinguishes his case from typical Kaposi's sarcoma presentations.
• The temporal association suggests a possible iatrogenic cause related to immunosuppression.

Implications:

• Corticosteroid therapy, even in the absence of HIV, may increase the risk of developing Kaposi's sarcoma.
• Physicians should consider the potential oncogenic effects of long-term immunosuppression in patients with autoimmune diseases.
• Further research is warranted to elucidate the mechanisms linking corticosteroid-induced immunosuppression to Kaposi's sarcoma in non-HIV individuals.